Warning
Island Kinetics Recalls Blemish Spot Treatment (Salicylic Acid) 1%
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0487-2026Drug / Pharmaceutical
Island Kinetics Recalls Blemish Spot Treatment (Salicylic Acid) 1%
Island Kinetics, Inc. d.b.a. CoValence Laboratories · Class II — Moderate Risk
Product Description
Blemish Spot Treatment (Salicylic Acid) 1%, .5 fl oz (15 ml) bottles, Skin Script, Chandler, AZ 85226, UPC 6 10563 13873 9.
Reason for Recall
Failed Stability Specifications
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
U.S. Nationwide
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
A Class II FDA recall has been issued for a pharmaceutical product from Island Kinetics, Inc. d.b.a. CoValence Laboratories, initiated on April 1, 2026. Failed Stability Specifications. This recall covers 28,163 bottles, distributed in U.S. Nationwide. While not the highest severity, consumers should exercise caution and stop using the product until the recall is resolved.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.